GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0006501
|
BP
|
C-terminal protein lipidation
|
The covalent attachment of a lipid group to the carboxy terminus of a protein.
|
ATG12
|
GO:0006505
|
BP
|
GPI anchor metabolic process
|
The chemical reactions and pathways involving glycosylphosphatidylinositol anchors, molecular mechanisms for attaching membrane proteins to the lipid bilayer of cell membranes. Structurally they consist of a molecule of phosphatidylinositol to which is linked, via the C-6 hydroxyl of the inositol, a carbohydrate chain. This chain is in turn linked to the protein through an ethanolamine phosphate group, the amino group of which is in amide linkage with the C-terminal carboxyl of the protein chain, the phosphate group being esterified to the C-6 hydroxyl of the terminal mannose of the core carbohydrate chain.
|
PIGW,
PGAP3
|
GO:0006506
|
BP
|
GPI anchor biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a glycosylphosphatidylinositol (GPI) anchor that attaches some membrane proteins to the lipid bilayer of the cell membrane. The phosphatidylinositol group is linked via the C-6 hydroxyl residue of inositol to a carbohydrate chain which is itself linked to the protein via an ethanolamine phosphate group, its amino group forming an amide linkage with the C-terminal carboxyl of the protein. Some GPI anchors have variants on this canonical linkage.
|
PIGA,
PIGF,
PIGH,
PIGY,
PIGG,
PIGC,
PGAP3,
PIGU,
CWH43,
DPM3
|
GO:0006507
|
BP
|
GPI anchor release
|
The GPI anchor metabolic process that results in enzymatic cleavage of the anchor, releasing an anchored protein from the membrane.
|
GPLD1
|
GO:0006508
|
BP
|
proteolysis
|
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
|
MASP2,
TPP1,
UBD,
CAPN5,
CFLAR,
ADAM12,
KLK10,
DHH,
NRDC,
TBL1X,
ADAM23,
PDCD6,
CAPN15,
PRSS23,
PAPLN,
ECEL1,
F8,
F2,
C1R,
PLG,
PLAU,
PLAT,
CFB,
C3,
C1QA,
MMP1,
CFI,
KLK3,
CTSD,
PRSS1,
CTSL,
CTSB,
CELA2A,
CELA2B,
MMP2,
MME,
MMP10,
DLD,
CTSH,
C1S,
C4A,
C4B,
MBL2,
F5,
BMP1,
IDE,
MMP9,
KLK2,
CAPN3,
MMP8,
MMP11,
CTSS,
MST1,
DPP4,
PSMB5,
LAP3,
PCSK1,
TPP2,
CASP1,
PDIA3,
SRI,
PRSS3,
DPP6,
CTSK,
PSMC4,
PREP,
CASP4,
MMP14,
MMP15,
MMP16,
THOP1,
CTSC,
CASP9,
CASP6,
NPEPPS,
YBEY,
ADAMTS20,
SHFM1,
ADAM8,
OLR1,
ADAM17,
HTRA3,
PMPCA,
CBLB,
PAPPA,
BLMH,
FGL2,
WFDC2,
ESPL1,
CASP8,
CUL7,
CLCA4,
PCOLCE,
FCN2,
NEDD8,
LONRF1,
LONRF2,
MST1L,
MMEL1,
LONRF3,
PREPL,
PITRM1,
CPZ,
CTRB2,
DESI1,
RHBDD2,
ERAP2,
ADAMTSL4,
THSD4,
ASRGL1,
ERMP1,
TRABD2A,
TMPRSS6,
PM20D2,
SFRP1,
MPND,
AOPEP,
ADAMTS17,
ADAMTS15,
ADAMTS18,
PIGK,
HTRA1,
GGH,
TANK,
NUDT16,
STAMBPL1,
CPB2,
AGBL1,
MMP19,
TMEM59,
NLN,
NDEL1,
ADAMTS10,
CAPN10,
ALG13,
MMP25,
NRIP3,
MMP26,
UFSP2,
PGPEP1,
C1RL,
ADAMTS9,
CTSZ,
CTSF,
ADAMTS1,
USP25,
LNPEP,
GGT7,
FBXL2,
ADAM21,
ADAMTS6,
SUFU,
ADAMTS5,
ADAMTS8,
AGTPBP1,
RCE1,
MYRF,
MMP24,
CPQ,
XRCC6BP1,
LOC440434
|
GO:0006509
|
BP
|
membrane protein ectodomain proteolysis
|
The proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain).
|
ADAM10,
MYH9,
RBMX,
PSEN1,
PSEN2,
ADAM17,
PRKCQ,
ADAM9,
DAG1,
SPPL2A,
APH1A,
ADAM19,
ERAP1
|
GO:0006511
|
BP
|
ubiquitin-dependent protein catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.
|
UBA6,
USP27X,
PSMD11,
UBE2C,
UBD,
PSMD3,
SIAH2,
USP12,
USP2,
RNF8,
USP1,
UBR5,
UCHL3,
XBP1,
USP6,
PSMC2,
RANBP1,
UBE2A,
USP11,
UBE2E1,
TTC3,
ATXN3,
UBE2D3,
USP46,
UBE2H,
PSMC6,
UBE2B,
UBE2I,
SQSTM1,
CUL7,
NEDD8,
UBR3,
USP34,
USP31,
USP51,
USP45,
USP48,
SIAH1,
TP53INP2,
FBXO22,
USP32,
FBXO25,
RFFL,
BAP1,
UFD1L,
USP13,
FBXO32,
ITCH,
USP28,
PINK1,
USP42,
SMURF2,
CYLD,
FBXO8,
RLIM,
DTL,
USP36,
USP35,
USP25,
FBXL7,
CDC23,
AMFR,
STUB1,
USP22,
RNF6,
BTRC,
USP20,
USP15,
ARIH1,
NUB1,
UCHL5
|
GO:0006513
|
BP
|
protein monoubiquitination
|
Addition of a single ubiquitin group to a protein.
|
PEX12,
PARK2,
UBE4B,
UBE2D3,
RBX1,
UBE2B,
CUL3,
TRIM25,
KLHL12,
HUWE1,
UBE2W,
NEDD4L,
RNF126,
UBE2T,
RAD18,
DTL,
FBXL2
|
GO:0006515
|
BP
|
misfolded or incompletely synthesized protein catabolic process
|
The chemical reactions and pathways resulting in the breakdown of misfolded or attenuated proteins.
|
ATXN3,
LONP2,
UBE2W,
OMA1,
YME1L1,
HDAC6,
STUB1
|
GO:0006516
|
BP
|
glycoprotein catabolic process
|
The chemical reactions and pathways resulting in the breakdown of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
|
MGEA5,
STT3B,
ADAMTS9
|
GO:0006517
|
BP
|
protein deglycosylation
|
The removal of sugar residues from a glycosylated protein.
|
MAN2B1,
MGEA5,
MAN2A2,
ENGASE,
MAN2B2
|
GO:0006518
|
BP
|
peptide metabolic process
|
The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.
|
MME,
CPM,
CPN1,
THOP1,
CPZ,
AEBP1,
MIPEP,
NLN
|
GO:0006520
|
BP
|
cellular amino acid metabolic process
|
The chemical reactions and pathways involving amino acids, carboxylic acids containing one or more amino groups, as carried out by individual cells.
|
QDPR,
ATF4,
SLC6A6,
MTHFR,
GLUD2,
SLC7A2,
SLC7A5,
CLN3,
SLC7A6,
SCLY,
SLC7A8,
SLC7A7,
SLC6A14,
SLC25A15
|
GO:0006521
|
BP
|
regulation of cellular amino acid metabolic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving amino acids.
|
PSMD11,
PSMD12,
AZIN1,
PSMD3,
PSMD10,
OAZ2,
INS,
ODC1,
NQO1,
PSMC3,
PSMB1,
PSMA1,
PSMA2,
PSMA3,
PSMA4,
PSMB8,
PSMB9,
PSMB4,
PSMB5,
PSMC2,
PSMB10,
PSMC4,
PSMB3,
PSMD7,
OAZ1,
PSME3,
PSMC1,
PSMC6,
PSMD2,
PSME4
|
GO:0006526
|
BP
|
arginine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of arginine, 2-amino-5-(carbamimidamido)pentanoic acid.
|
ASS1,
CAD
|
GO:0006527
|
BP
|
arginine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid.
|
DDAH1,
DDAH2,
FAH,
NOS3
|
GO:0006529
|
BP
|
asparagine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of asparagine, 2-amino-3-carbamoylpropanoic acid.
|
ASNS
|
GO:0006531
|
BP
|
aspartate metabolic process
|
The chemical reactions and pathways involving aspartate, the anion derived from aspartic acid, 2-aminobutanedioic acid.
|
GOT2,
ASS1,
ADSS,
ADSSL1
|
GO:0006532
|
BP
|
aspartate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of aspartate, the anion derived from aspartic acid, 2-aminobutanedioic acid.
|
GOT2,
BCAT1
|
GO:0006533
|
BP
|
aspartate catabolic process
|
The chemical reactions and pathways resulting in the breakdown of aspartate, the anion derived from aspartic acid, 2-aminobutanedioic acid.
|
GOT2
|
GO:0006534
|
BP
|
cysteine metabolic process
|
The chemical reactions and pathways involving cysteine, 2-amino-3-mercaptopropanoic acid.
|
CTH,
GCLC,
GCLM,
CDO1
|
GO:0006535
|
BP
|
cysteine biosynthetic process from serine
|
The chemical reactions and pathways resulting in the formation of cysteine from other compounds, including serine.
|
CBS
|
GO:0006536
|
BP
|
glutamate metabolic process
|
The chemical reactions and pathways involving glutamate, the anion of 2-aminopentanedioic acid.
|
GOT2,
GCLC,
GCLM,
GLUD2,
MTHFS,
ALDH18A1
|
GO:0006537
|
BP
|
glutamate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of glutamate, the anion of 2-aminopentanedioic acid.
|
GLS,
SLC1A3,
GLUD2
|
GO:0006538
|
BP
|
glutamate catabolic process
|
The chemical reactions and pathways resulting in the breakdown of glutamate, the anion of 2-aminopentanedioic acid.
|
GLUD2
|
GO:0006541
|
BP
|
glutamine metabolic process
|
The chemical reactions and pathways involving glutamine, 2-amino-4-carbamoylbutanoic acid.
|
PFAS,
PHGDH,
ASNS,
CTPS1,
CAD,
GMPS,
GFPT1,
ADSSL1,
GGH,
CTPS2
|
GO:0006543
|
BP
|
glutamine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of glutamine, 2-amino-4-carbamoylbutanoic acid.
|
GLS,
PPAT
|
GO:0006544
|
BP
|
glycine metabolic process
|
The chemical reactions and pathways involving glycine, aminoethanoic acid.
|
PHGDH,
GART,
SHMT1,
DMGDH
|
GO:0006545
|
BP
|
glycine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of glycine, aminoethanoic acid.
|
DHFR
|
GO:0006546
|
BP
|
glycine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of glycine, aminoethanoic acid.
|
GCSH
|
GO:0006548
|
BP
|
histidine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of histidine, 2-amino-3-(1H-imidazol-4-yl)propanoic acid.
|
HNMT
|
GO:0006549
|
BP
|
isoleucine metabolic process
|
The chemical reactions and pathways involving isoleucine, (2R*,3R*)-2-amino-3-methylpentanoic acid.
|
GHR,
STAT5A,
STAT5B
|
GO:0006552
|
BP
|
leucine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of leucine, 2-amino-4-methylpentanoic acid.
|
HMGCL,
AUH,
MCCC1,
MCCC2
|
GO:0006554
|
BP
|
lysine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of lysine, 2,6-diaminohexanoic acid.
|
DLD,
DLST,
ALDH7A1,
OGDH,
PHYKPL,
PIPOX,
AASS
|
GO:0006555
|
BP
|
methionine metabolic process
|
The chemical reactions and pathways involving methionine (2-amino-4-(methylthio)butanoic acid), a sulfur-containing, essential amino acid found in peptide linkage in proteins.
|
MTHFD1,
MTHFR
|
GO:0006556
|
BP
|
S-adenosylmethionine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of S-adenosylmethionine, S-(5'-adenosyl)-L-methionine, an important intermediate in one-carbon metabolism.
|
MAT2A,
MAT2B
|
GO:0006557
|
BP
|
S-adenosylmethioninamine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of S-adenosylmethioninamine, (5-deoxy-5-adenosyl)(3-aminopropyl) methylsulfonium salt.
|
AMD1
|
GO:0006559
|
BP
|
L-phenylalanine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of phenylalanine, 2-amino-3-phenylpropanoic acid.
|
GSTZ1,
QDPR,
FAH,
ASRGL1,
HGD
|
GO:0006560
|
BP
|
proline metabolic process
|
The chemical reactions and pathways involving proline (pyrrolidine-2-carboxylic acid), a chiral, cyclic, nonessential alpha-amino acid found in peptide linkage in proteins.
|
PRODH
|
GO:0006561
|
BP
|
proline biosynthetic process
|
The chemical reactions and pathways resulting in the formation of proline (pyrrolidine-2-carboxylic acid), a chiral, cyclic, nonessential alpha-amino acid found in peptide linkage in proteins.
|
ALDH18A1
|
GO:0006562
|
BP
|
proline catabolic process
|
The chemical reactions and pathways resulting in the breakdown of proline (pyrrolidine-2-carboxylic acid), a chiral, cyclic, nonessential alpha-amino acid found in peptide linkage in proteins.
|
PRODH
|
GO:0006563
|
BP
|
L-serine metabolic process
|
The chemical reactions and pathways involving L-serine, the L-enantiomer of serine, i.e. (2S)-2-amino-3-hydroxypropanoic acid.
|
SHMT1,
CBS
|
GO:0006564
|
BP
|
L-serine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of L-serine, the L-enantiomer of serine, i.e. (2S)-2-amino-3-hydroxypropanoic acid.
|
PHGDH,
PSAT1
|
GO:0006565
|
BP
|
L-serine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of L-serine, the L-enantiomer of serine, i.e. (2S)-2-amino-3-hydroxypropanoic acid.
|
SHMT1,
CBS
|
GO:0006566
|
BP
|
threonine metabolic process
|
The chemical reactions and pathways involving threonine (2-amino-3-hydroxybutyric acid), a polar, uncharged, essential amino acid found in peptide linkage in proteins.
|
PHGDH
|
GO:0006569
|
BP
|
tryptophan catabolic process
|
The chemical reactions and pathways resulting in the breakdown of tryptophan, the chiral amino acid 2-amino-3-(1H-indol-3-yl)propanoic acid.
|
KMO,
KYNU
|
GO:0006572
|
BP
|
tyrosine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of tyrosine, an aromatic amino acid, 2-amino-3-(4-hydroxyphenyl)propanoic acid.
|
GSTZ1,
FAH,
HGD
|
GO:0006573
|
BP
|
valine metabolic process
|
The chemical reactions and pathways involving valine, 2-amino-3-methylbutanoic acid.
|
GHR,
STAT5A,
STAT5B,
ALDH6A1
|
GO:0006574
|
BP
|
valine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of valine, 2-amino-3-methylbutanoic acid.
|
HIBADH,
ALDH6A1,
HIBCH
|
GO:0006576
|
BP
|
cellular biogenic amine metabolic process
|
The chemical reactions and pathways occurring at the level of individual cells involving any of a group of naturally occurring, biologically active amines, such as norepinephrine, histamine, and serotonin, many of which act as neurotransmitters.
|
MAOA
|
GO:0006579
|
BP
|
amino-acid betaine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of any betaine, the N-trimethyl derivative of an amino acid.
|
DMGDH
|
GO:0006580
|
BP
|
ethanolamine metabolic process
|
The chemical reactions and pathways involving ethanolamine (2-aminoethanol), an important water-soluble base of phospholipid (phosphatidylethanolamine).
|
CHKA
|
GO:0006582
|
BP
|
melanin metabolic process
|
The chemical reactions and pathways involving melanins, pigments largely of animal origin. High molecular weight polymers of indole quinone, they are irregular polymeric structures and are divided into three groups: allomelanins in the plant kingdom and eumelanins and phaeomelanins in the animal kingdom.
|
BCL2
|
GO:0006583
|
BP
|
melanin biosynthetic process from tyrosine
|
The chemical reactions and pathways resulting in the formation of melanin from other compounds, including tyrosine.
|
TYR
|
GO:0006584
|
BP
|
catecholamine metabolic process
|
The chemical reactions and pathways involving any of a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.
|
AOC2,
SULT1A3,
MTPN
|
GO:0006585
|
BP
|
dopamine biosynthetic process from tyrosine
|
The chemical reactions and pathways resulting in the formation of dopamine (3,4-dihydroxyphenylethylamine) from L-tyrosine, via the metabolic precursor 3,4-dihydroxy-L-phenylalanine (L-dopa). Dopamine is a catecholamine neurotransmitter and a metabolic precursor of norepinephrine and epinephrine.
|
TH
|
GO:0006590
|
BP
|
thyroid hormone generation
|
The formation of either of the compounds secreted by the thyroid gland, mainly thyroxine and triiodothyronine. This is achieved by the iodination and joining of tyrosine molecules to form the precursor thyroglobin, proteolysis of this precursor gives rise to the thyroid hormones.
|
DIO2,
SLC5A5,
DUOX2,
DUOX1,
CPQ
|
GO:0006592
|
BP
|
ornithine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of ornithine, an amino acid only rarely found in proteins, but which is important in living organisms as an intermediate in the reactions of the urea cycle and in arginine biosynthesis.
|
ALDH18A1
|
GO:0006595
|
BP
|
polyamine metabolic process
|
The chemical reactions and pathways involving polyamines, any organic compound containing two or more amino groups.
|
OAZ2,
ODC1,
AMD1,
SRM
|
GO:0006596
|
BP
|
polyamine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of polyamines, any organic compound containing two or more amino groups.
|
OAZ2,
SAT1,
OAZ1
|
GO:0006597
|
BP
|
spermine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of spermine, a polybasic amine found in human sperm, in ribosomes and in some viruses and involved in nucleic acid packaging.
|
AMD1
|
GO:0006600
|
BP
|
creatine metabolic process
|
The chemical reactions and pathways involving creatine (N-(aminoiminomethyl)-N-methylglycine), a compound synthesized from the amino acids arginine, glycine, and methionine that occurs in muscle.
|
GHR,
CKB,
CKMT1A,
CKMT2,
STAT5A,
SLC6A8,
GATM,
STAT5B
|
GO:0006601
|
BP
|
creatine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of creatine, N-[amino(imino)methyl]-N-methylglycine. Creatine is formed by a process beginning with amidino group transfer from L-arginine to glycine to form guanidinoacetate, followed by methyl group transfer from S-adenosyl-L-methionine to guanidinoacetate; it is then is phosphorylated to form a pool that stores high energy phosphate for the replenishment of ATP during periods of high, or fluctuating energy demand. In animals, most creatine is transported to and used in muscle.
|
GATM
|
GO:0006605
|
BP
|
protein targeting
|
The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif.
|
MYO1C,
RHOD,
TRAK2,
RASSF9,
YWHAB,
RAB27A,
SYNJ2BP,
YWHAE,
RPL11,
YWHAZ,
AKAP6,
OS9,
CDC37,
PAN3,
NLGN1,
SORL1,
KATNB1,
HPS4,
KIF13B,
HOMER3,
TRAK1
|
GO:0006606
|
BP
|
protein import into nucleus
|
The directed movement of a protein from the cytoplasm to the nucleus.
|
NUP155,
PDIA3,
FGF9,
NUP62,
STAT3,
RANBP1,
NUP153,
TSC2,
PTTG1IP,
CSE1L,
NUP107,
NUTF2,
RAE1,
PPP3CA,
KPNB1,
C11orf73,
NUP93,
TMCO6,
PRICKLE1,
IPO9,
PPP1R10,
NUP88,
NUP58,
NUP85,
NUP62CL,
TXNIP,
NUP50
|
GO:0006607
|
BP
|
NLS-bearing protein import into nucleus
|
The directed movement of a protein bearing a nuclear localization signal (NLS) from the cytoplasm into the nucleus, across the nuclear membrane.
|
IPO5,
KPNA3,
KPNA4,
TNPO2,
FYB,
KPNA5,
RANBP6,
RANBP2,
KPNA2,
KPNA1,
CBLB,
DAG1,
KPNB1,
NUP35,
IPO4,
RERE,
TRPS1
|
GO:0006610
|
BP
|
ribosomal protein import into nucleus
|
The directed movement of a ribosomal protein from the cytoplasm into the nucleus, across the nuclear membrane.
|
IPO5,
TNPO2,
RANBP6,
KPNB1,
IPO4
|
GO:0006611
|
BP
|
protein export from nucleus
|
The directed movement of a protein from the nucleus into the cytoplasm.
|
XPO1,
NUPL2,
AHCYL1,
TGFB1,
EGR2,
CALR,
GSK3B,
CSE1L,
NUTF2,
EIF5A,
CRB1,
PKD1,
NUP88,
CHP1,
XPO4,
STRADB,
NXT1
|
GO:0006612
|
BP
|
protein targeting to membrane
|
The process of directing proteins towards a membrane, usually using signals contained within the protein.
|
MYO1C,
SDCBP,
ICMT,
CHM,
ADORA1,
PRKCI,
PARD3,
RAB3IP,
SEC63,
RABGEF1,
TAOK2
|
GO:0006613
|
BP
|
cotranslational protein targeting to membrane
|
The targeting of proteins to a membrane that occurs during translation. The transport of most secretory proteins, particularly those with more than 100 amino acids, into the endoplasmic reticulum lumen occurs in this manner, as does the import of some proteins into mitochondria.
|
SRP14,
SSR1,
TRAM2,
ARL6IP1,
SEC62
|
GO:0006614
|
BP
|
SRP-dependent cotranslational protein targeting to membrane
|
The targeting of proteins to a membrane that occurs during translation and is dependent upon two key components, the signal-recognition particle (SRP) and the SRP receptor. SRP is a cytosolic particle that transiently binds to the endoplasmic reticulum (ER) signal sequence in a nascent protein, to the large ribosomal unit, and to the SRP receptor in the ER membrane.
|
SRP72,
RPLP1,
RPLP2,
RPLP0,
RPS17,
RPSA,
RPS2,
RPL35A,
RPL7,
RPL17,
RPS4Y1,
RPL13,
RPL10,
RPL12,
RPL22,
RPL4,
SRP14,
RPL13A,
RPS27,
RPL35,
RPL27A,
RPL5,
RPL21,
RPL28,
RPS9,
RPS5,
RPS10,
RPL29,
RPL34,
SRP9,
RPL14,
RPS20,
SRP54,
RPS3A,
RPL26,
RPL15,
RPL27,
RPL37A,
SEC61A1,
RPL37,
RPS7,
RPS8,
RPS15A,
RPS16,
RPS14,
RPS18,
RPS13,
RPS11,
RPL7A,
RPL23A,
RPS6,
RPS25,
RPS26,
RPL30,
RPL31,
RPL10A,
RPL32,
RPL11,
RPL41,
RPS27A,
UBA52,
RPL38,
RPS21,
RPL24,
RPL36A,
RPL19,
RPL18A,
RPL18,
SEC63,
SSR3,
RPL36,
SRPRB
|
GO:0006616
|
BP
|
SRP-dependent cotranslational protein targeting to membrane, translocation
|
The process during cotranslational membrane targeting wherein proteins move across a membrane. SRP and its receptor initiate the transfer of the nascent chain across the endoplasmic reticulum (ER) membrane; they then dissociate from the chain, which is transferred to a set of transmembrane proteins, collectively called the translocon. Once the nascent chain translocon complex is assembled, the elongating chain passes directly from the large ribosomal subunit into the centers of the translocon, a protein-lined channel within the membrane. The growing chain is never exposed to the cytosol and does not fold until it reaches the ER lumen.
|
SRP9,
SRP54,
ZFAND2B
|
GO:0006617
|
BP
|
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition
|
The process in which SRP binds to the signal peptide in a nascent protein, causing protein elongation to pause, during cotranslational membrane targeting.
|
SRP54
|
GO:0006620
|
BP
|
posttranslational protein targeting to membrane
|
The targeting of proteins to a membrane that occurs after their translation. Some secretory proteins exhibit posttranslational transport into the endoplasmic reticulum (ER) lumen: they are synthesized in their entirety on free cytosolic ribosomes and then released into the cytosol, where they are bound by chaperones which keep them in an unfolded state, and subsequently are translocated across the ER membrane.
|
SEC61A1,
SEC62,
CHMP4B,
SEC63
|
GO:0006621
|
BP
|
protein retention in ER lumen
|
The retention in the endoplasmic reticulum (ER) lumen of soluble resident proteins. Sorting receptors retrieve proteins with ER localization signals, such as KDEL and HDEL sequences or some transmembrane domains, that have escaped to the cis-Golgi network and return them to the ER. Abnormally folded proteins and unassembled subunits are also selectively retained in the ER.
|
KDELR3,
KDELR1,
PDIA3,
OS9
|
GO:0006622
|
BP
|
protein targeting to lysosome
|
The process of directing proteins towards the lysosome using signals contained within the protein.
|
RAB7A,
SNX16,
NCOA4,
ZFYVE16,
SORL1,
NAGPA,
AP3M1
|
GO:0006623
|
BP
|
protein targeting to vacuole
|
The process of directing proteins towards the vacuole, usually using signals contained within the protein.
|
GOSR2,
VPS13C,
PIK3R4,
VTI1B
|
GO:0006625
|
BP
|
protein targeting to peroxisome
|
The process of directing proteins towards the peroxisome, usually using signals contained within the protein.
|
PEX12,
ZFAND6,
LONP2
|
GO:0006626
|
BP
|
protein targeting to mitochondrion
|
The process of directing proteins towards and into the mitochondrion, usually mediated by mitochondrial proteins that recognize signals contained within the imported protein.
|
AIP,
TIMM23,
TIMM17B,
MFN2,
TOMM40,
TSPO,
BID,
TOMM20,
TOMM5,
MGARP,
DNAJC19,
TRNT1,
TIMM17A,
MFF,
TOMM22,
TOMM7,
TIMM10B
|
GO:0006627
|
BP
|
protein processing involved in protein targeting to mitochondrion
|
The cleavage of peptide bonds in proteins, usually near the N terminus, contributing to the process of import into the mitochondrion. Several different peptidases mediate cleavage of proteins destined for different mitochondrial compartments.
|
PMPCA,
MIPEP
|
GO:0006629
|
BP
|
lipid metabolic process
|
The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
|
PLPP1,
PLPP3,
TPP1,
MGST3,
PLIN1,
ACSL4,
SC5D,
CH25H,
LDLR,
APOC1,
APOD,
CYP3A4,
CLU,
G6PD,
PC,
CD36,
IL1RN,
PTGS1,
NR2F2,
AOAH,
CHKA,
HMGCL,
SREBF1,
PPARG,
LEP,
ALDH3B2,
PITPNB,
FABP6,
UCP3,
PAFAH1B2,
LRP2,
PITPNA,
FABP5,
HMGCS1,
OCRL,
PPARD,
PPARA,
SREBF2,
PDE3A,
STARD3,
ACOX1,
PAFAH1B3,
PLCL1,
PLA1A,
TECRL,
SLC27A4,
BTN2A1,
NPHP3,
LRP10,
JAZF1,
TPRA1,
CNEP1R1,
TRPV1,
ABHD4,
OMA1,
FAR2,
MGLL,
HSD17B10,
APOL2,
ACAT2,
OSBPL10,
MID1IP1,
GDE1,
PEMT,
PLCL2,
LIPT1,
LIPG,
CEPT1
|
GO:0006631
|
BP
|
fatty acid metabolic process
|
The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
|
NDUFS6,
LYPLA1,
LYPLA2,
C3,
FABP3,
TH,
GHR,
PRKAR2B,
SNCA,
STAT5A,
ACADSB,
FASN,
STAT5B,
UCP3,
CREM,
PPARA,
MSMO1,
AASDH,
THEM4,
FA2H,
GPAT4,
AACS,
ABHD5,
ALKBH7,
MECR,
GPAM,
PNPLA8,
CROT,
CRYL1
|
GO:0006633
|
BP
|
fatty acid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.
|
HACD1,
ACACB,
NDUFAB1,
SC5D,
CH25H,
LPL,
XBP1,
ABCD3,
BRCA1,
FASN,
PRKAG1,
PRKAA2,
MSMO1,
ACSM3,
HSD17B12,
FA2H,
MGLL,
MECR,
ELOVL4,
PRKAG3
|
GO:0006635
|
BP
|
fatty acid beta-oxidation
|
A fatty acid oxidation process that results in the complete oxidation of a long-chain fatty acid. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and occurs by successive cycles of reactions during each of which the fatty acid is shortened by a two-carbon fragment removed as acetyl coenzyme A; the cycle continues until only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
|
SLC27A2,
SLC25A17,
ECI2,
ABCD3,
ECHS1,
LEP,
ECI1,
ACADVL,
CPT1A,
HSD17B4,
HADHB,
SESN2,
PPARD,
ECH1,
AUH,
ADIPOQ,
DECR1,
HADH,
HIBCH,
ECHDC2,
CPT1B,
BDH2,
ACAT2,
CROT
|
GO:0006636
|
BP
|
unsaturated fatty acid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of an unsaturated fatty acid, any fatty acid containing one or more double bonds between carbon atoms.
|
ELOVL7,
SCD,
FADS1,
FADS2,
SCD5,
ELOVL1,
ELOVL4,
ELOVL6,
ELOVL5
|
GO:0006637
|
BP
|
acyl-CoA metabolic process
|
The chemical reactions and pathways involving acyl-CoA, any derivative of coenzyme A in which the sulfhydryl group is in thiolester linkage with an acyl group.
|
ACOT8,
HMGCL,
GPAT4,
ACOT4,
GPAM,
ACSL6,
ACOT9
|
GO:0006638
|
BP
|
neutral lipid metabolic process
|
The chemical reactions and pathways involving neutral lipids, lipids only soluble in solvents of very low polarity.
|
SNCA
|
GO:0006641
|
BP
|
triglyceride metabolic process
|
The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.
|
INSIG1,
ACSL4,
APOE,
APOA2,
APOC1,
APOC3,
APOH,
CYP2E1,
LPL,
GPX1,
GK,
ACSL1,
G6PC,
CPT1A,
CAV1,
PTPN11,
APOBR,
APOA5,
PCSK9,
LMF1,
SEL1L
|
GO:0006642
|
BP
|
triglyceride mobilization
|
The release of triglycerides, any triester of glycerol, from storage within cells or tissues, making them available for metabolism.
|
APOB,
LPIN1
|
GO:0006643
|
BP
|
membrane lipid metabolic process
|
The chemical reactions and pathways involving membrane lipids, any lipid found in or associated with a biological membrane.
|
B4GALT4
|
GO:0006644
|
BP
|
phospholipid metabolic process
|
The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester.
|
PLPP1,
PLPP3,
APOA1,
LPL,
PLA2G2A,
GPX4,
SNCA,
PLA2G5,
NKX2-1,
PLA2G4A,
PLCD1,
PLA2G16,
PLPPR4,
PCSK9,
PLPP5,
ABHD4,
GATA6,
PLPPR2,
ACP6,
LGALS13,
PLA2G4C,
PLAA
|
GO:0006646
|
BP
|
phosphatidylethanolamine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
|
ALOX15,
CHKA,
LPIN1,
SLC27A1,
PCYT2,
EPT1,
ETNK1,
CHKB,
CEPT1
|
GO:0006650
|
BP
|
glycerophospholipid metabolic process
|
The chemical reactions and pathways involving glycerophospholipids, any derivative of glycerophosphate that contains at least one O-acyl, O-alkyl, or O-alkenyl group attached to the glycerol residue.
|
GNPAT,
PEMT
|
GO:0006651
|
BP
|
diacylglycerol biosynthetic process
|
The chemical reactions and pathways resulting in the formation of diacylglycerol, a glyceride in which any two of the R groups (positions not specified) are acyl groups while the remaining R group can be either H or an alkyl group.
|
ANG
|
GO:0006654
|
BP
|
phosphatidic acid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids.
|
GNPAT,
PLA2G2A,
PLA2G5,
PLA2G4A,
PLD1,
GPAT3,
SLC27A1,
LCLAT1,
GPAT4,
ABHD5,
PLA2G12A,
GPAM,
AGPAT4,
AGPAT3
|
GO:0006655
|
BP
|
phosphatidylglycerol biosynthetic process
|
The chemical reactions and pathways resulting in the formation of phosphatidylglycerols, any of a class of phospholipids in which the phosphatidyl group is esterified to the hydroxyl group of glycerol.
|
CDS2,
PGS1,
SLC27A1,
CDS1
|
GO:0006656
|
BP
|
phosphatidylcholine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
|
APOA1,
APOA2,
CHKA,
PCYT1A,
FABP5,
LPIN1,
SLC27A1,
GPAT4,
SLC44A2,
SLC44A3,
SLC44A5,
SLC44A1,
PEMT,
CHKB,
PCYT1B,
CEPT1
|
GO:0006657
|
BP
|
CDP-choline pathway
|
The phosphatidylcholine biosynthetic process that begins with the phosphorylation of choline and ends with the combination of CDP-choline with diacylglycerol to form phosphatidylcholine.
|
CHKA,
PCYT1A,
CDS1,
CHKB,
PCYT1B,
CEPT1
|
GO:0006658
|
BP
|
phosphatidylserine metabolic process
|
The chemical reactions and pathways involving phosphatidylserines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of L-serine. They are important constituents of cell membranes.
|
SERINC3,
PLA1A,
SERINC5,
SERINC2,
SERINC1
|
GO:0006659
|
BP
|
phosphatidylserine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of phosphatidylserines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of L-serine.
|
PLSCR1,
PTDSS1,
SLC27A1
|